Morgan Stanley Regencell Bioscience Holdings LTD Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Regencell Bioscience Holdings LTD stock. As of the latest transaction made, Morgan Stanley holds 33,020 shares of RGC stock, worth $564,642. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,020
Previous 5
660300.0%
Holding current value
$564,642
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RGC
# of Institutions
14Shares Held
638KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA391KShares$6.69 Million0.0% of portfolio
-
Squarepoint Ops LLC New York, NY99.8KShares$1.71 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY52.1KShares$890,9100.01% of portfolio
-
Ubs Group Ag37.5KShares$641,7110.0% of portfolio
-
Y Intercept (Hong Kong) LTD13KShares$223,0180.01% of portfolio
About Regencell Bioscience Holdings Ltd
- Ticker RGC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,012,900
- Market Cap $223M
- Description
- Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...